MedTrace Logo

evaluatioN de la perfOrMAnce De Capteurs E-textiles

NCT04069390 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-11-13

No results posted yet for this study

Summary

The NOMADE study has a dual purpose:

* Test the performance of new types of sensors that are likely to integrate Bioserenity devices and will therefore improve them.
* Test the performance of the sensors of Bioserenity CE devices and their advanced versions

Different EC and non-CE models of Neuronaute and Cardioskin may be tested in this study.

Conditions

  • Healthy Volunteers Without Any Cardiac or Any Neurological Disorders

Interventions

DEVICE

CARDIOSKIN - Short record

A short record (max 2H15) is performed with Cardioskin

DEVICE

Cardioskin - long record

A long record (max 8H) is performed with Cardioskin

DEVICE

Neuronaute - long record

A long record (max 8H) is performed with Neuronaute

DEVICE

Neuronaute -short record

A short record (max 2H15) is performed with Neuronaute

Sponsors & Collaborators

  • BioSerenity

    lead INDUSTRY

Principal Investigators

  • remy WAHNOUN · BioSerenity

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-09
Primary Completion
2021-01-09
Completion
2021-01-09

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069390 on ClinicalTrials.gov